Derivation of clinical grade transgene-free human iPSC using a newly developed measles reprogramming system for the treatment of diabetes.
Research Grant Recipient: Patricia Devaux, PhD
Grant Period: 2017-2019
Award Value: $250,000
Site: Mayo Clinic
Summary: Dr. Devaux is testing a new way of making human blood cells go back to a state from which they can then develop into other kinds of cells, particularly insulin-producing cells that could help diabetic patients
Patricia Devaux, PhD, is an Assistant Professor of Biochemistry and Molecular Biology at Mayo Clinic. She also a researcher with the Gene and Virus Therapy Program, Center for Regenerative Medicine, Mayo Clinic Cancer Center, and Molecular Medicine.